Researchers at the National University of Singapore have created a new platform with the potential to extract tiny circulating biomarkers of disease from patient blood. This simple, fast and convenient technique could help realize liquid biopsy diagnostics—a less invasive procedure than the current gold standard: tumor biopsies. Details of the new technique, which utilizes standard laboratory equipment, are reported this week in Biomicrofluidics.